Brief: Medibio Updates On Breakthrough Device Designation With US FDA

TrivarX

21/07/2023 02:21

July 21 (Reuters) - Medibio Ltd  MEB.AX :
    * UPDATE ON BREAKTHROUGH DEVICE DESIGNATION WITH US FDA
    * US FDA NOTIFIED CO THAT MEB-001 IN ITS CURRENT FORM DOES
NOT
MEET CRITERIA FOR DESIGNATION AS BREAKTHROUGH DEVICE
    * EXPECTS TO SCHEDULE A PRE-SUBMISSION MEETING WITH
REGULATORY
BODY DURING Q4 CY2023

Source text for Eikon:  ID:nASXt8dBy 
Further company coverage:  MEB.AX 

 ((Reuters.Briefs@thomsonreuters.com;))